<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="72211">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01934842</url>
  </required_header>
  <id_info>
    <org_study_id>13-P005</org_study_id>
    <nct_id>NCT01934842</nct_id>
  </id_info>
  <brief_title>A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate</brief_title>
  <official_title>A Study to Compare Analyte Levels in Blood Samples Collected Using the TAP20-C Device With Results Obtained by Fingerstick Using the SAFE-T-FILL Capillary Blood Collection System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seventh Sense Biosystems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seventh Sense Biosystems</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare blood collection from the forearm using an investigational device,
      TAP20-C to blood collection from the finger tip. The blood collected from the forearm and
      from the fingertip will then be analyzed for glucose, hemoglobin and hemoglobin A1c.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">February 2014</completion_date>
  <primary_completion_date type="Anticipated">February 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Non Inferiority of Analyte Levels</measure>
    <time_frame>Day 1</time_frame>
    <safety_issue>No</safety_issue>
    <description>The study will compare the concentrations of glucose, hemoglobin and hemoglobin A1c in blood samples collected with the two different blood collection methods in a single 2 1/2 hour session.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Diabetes</condition>
  <condition>Anemia</condition>
  <arm_group>
    <arm_group_label>TAP20-C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>TAP20-C</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SAFE-T-FILL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>SAFE-T-FILL</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TAP20-C</intervention_name>
    <arm_group_label>TAP20-C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>SAFE-T-FILL</intervention_name>
    <arm_group_label>SAFE-T-FILL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Healthy Subject Group

          1. Male and female volunteers 18 years of age or older.

          2. Voluntary written consent to participate in this study.

        Diabetic Subject Group

          1. Male and female volunteers 18 years of age or older.

          2. Have been diagnosed with Type 1 or Type 2 diabetes mellitus by self-report.

          3. Voluntary written consent to participate in this study.

        Exclusion Criteria:

          1. Subjects who are pregnant or nursing mothers by self-report.

          2. Subjects who have eaten or consumed sugar-containing drinks in the 2 hours before
             blood sample collection begins.

          3. Subjects with a history of skin disorders or who present with abnormal skin integrity
             or atypical skin health within the areas to be tested.

          4. Subjects with a missing index or middle finger on either hand or a missing forearm

          5. Subjects who have known allergies to titanium.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Seventh Sense Biosytems</name>
      <address>
        <city>Cambridge</city>
        <state>Massachusetts</state>
        <zip>02141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Howaard Bernstein, MD, PhD</last_name>
      <phone>617-547-7246</phone>
      <phone_ext>220</phone_ext>
      <email>hbernstein@7sbio.com</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2013</verification_date>
  <lastchanged_date>September 3, 2013</lastchanged_date>
  <firstreceived_date>August 30, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Anemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
